CLEARDX LABS
LIVE

Serial Number

97291710

Owner

CLEARDX LABS INC.

Attorney

Paulo A. de Almeida

Filing Date

Mar 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CLEARDX LABS Trademark

Serial Number: 97291710

CLEARDX LABS is a trademark filed by CLEARDX LABS INC. on March 2, 2022. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

CLEARDX LABS INC. (2 trademarks)

76 T.W. Alexander Drive
Research Triangle Park, NC 27709

Entity Type: 03

Trademark Details

Filing Date

March 2, 2022

Registration Date

Not Registered

Goods & Services

: Providing medical laboratory services and laboratory analysis in the field of infectious diseases; Scientific research and pharmaceutical drug development and testing services; research and development of pharmaceuticals, in-vitro diagnostic tests, medical devices, biotechnology, and biochemicals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on in vitro diagnostic tests, pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on in-vitro diagnostic tests, pharmaceuticals and medical devices; Scientific research, namely, collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; rental of laboratory apparatus and instruments; operating and maintaining on-line databases for others in the nature of a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; Genetic testing of laboratory animals for scientific research purposes; computer hardware and software design; development, updating and maintenance of software and databases systems; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical and medical device and development studies; Scientific research, namely, analytical testing on investigational tests; food safety testing and consultation related thereto; scientific research and analysis in the fields of food safety, food packaging, and nutritional chemistry; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals and clinical trials; providing medical laboratory services and laboratory analysis in the fields including but not limited to pathology pharmacology, and immunology and infectious diseases

Medical devices for monitoring vital signs, blood properties and respiratory events

Clinical testing services in the nature of medical testing for diagnostic or treatment purposes; providing medical information; providing a website featuring medical information; medical information services, namely, reporting medical testing results to customers; medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; providing medical testing for diagnostic or treatment purposes; Medical diagnostic testing in the nature of in vitro diagnostics

Business consulting services in the field of commercialization of pharmaceuticals, medical devices, biotechnology, and biochemicals; business management services, namely, forecasting laboratory supplies for clinical trials; business management services, namely, recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; project management services for others for business purposes in the field of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; database management; business information services; business data analysis; business advice and commercial information

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 22, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 6, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 5, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 3, 2024 RCSC
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 24, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 24, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 24, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 24, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 24, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 24, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 24, 2024 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 26, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 28, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 27, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 27, 2023 GNSL
SUSPENSION LETTER WRITTEN
Feb 27, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 27, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 13, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2022 NWOS
NEW APPLICATION ENTERED
Mar 5, 2022 NWAP